Improving laboratory testing for HIV/AIDS treatment and prevention
Immunology Quality Assessment (IQA) Program
This study is all about helping labs that do important HIV/AIDS tests to make sure they can do their jobs well and safely, so that the information they gather can lead to better treatments and prevention methods for everyone affected by the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11192198 on NIH RePORTER |
What this research studies
This research focuses on enhancing the capabilities of laboratories involved in HIV/AIDS clinical studies by ensuring they can reliably perform necessary immunological tests and properly handle biological samples. It aims to standardize and validate testing methodologies, particularly for laboratory-developed tests, to meet regulatory standards. By monitoring and supporting laboratories, the project seeks to improve the overall quality of data collected in clinical studies, which is crucial for effective treatment and prevention strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals involved in or affected by HIV/AIDS, particularly those participating in clinical studies that require laboratory testing.
Not a fit: Patients who are not involved in HIV/AIDS clinical studies or who do not require laboratory testing for their condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and reliable laboratory testing for HIV/AIDS, ultimately improving patient care and treatment outcomes.
How similar studies have performed: Previous research has shown that improving laboratory practices and standardizing testing methods can significantly enhance the quality of clinical study outcomes, indicating a strong potential for success in this approach.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Denny, Thomas — Duke University
- Study coordinator: Denny, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.